leadf
logo-loader
AIM:AGL

ANGLE PLC

Receive alerts
Market:
AIM
Market Cap:
£132.5 m
Price
61.50 GBX
Change
1.65%
52 weeks high
79.50
52 weeks low
37.15

In brief

ANGLE PLC develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease.

Snapshot

  • ANGLE is developing Parsortix blood test that can detect cancer
  • Healthy cash balance
  • Other tests in development